Bispecific antibodies: molecules that enable novel therapeutic strategies - PubMed (original) (raw)
Review
Bispecific antibodies: molecules that enable novel therapeutic strategies
Nicolas Fischer et al. Pathobiology. 2007.
Abstract
Bispecific antibodies are unique in the sense that they can bind simultaneously two different antigens. This property enables the development of therapeutic strategies that are not possible with conventional monoclonal antibodies. The large panel of imaginative bispecific antibody formats that has been developed reflects the strong interest for these molecules. Although in many cases the manufacturing of clinical grade material remains challenging, several bispecific antibody formats are currently in clinical trials.
Copyright (c) 2007 S. Karger AG, Basel.
Comment in
- Paul Ehrlich no end: antibodies as therapeutic molecules.
Borisch B. Borisch B. Pathobiology. 2007;74(1):1-2. doi: 10.1159/000101045. Pathobiology. 2007. PMID: 17496427 No abstract available.
Similar articles
- Bispecific antibodies for cancer therapy.
Hollander N. Hollander N. Immunotherapy. 2009 Mar;1(2):211-22. doi: 10.2217/1750743X.1.2.211. Immunotherapy. 2009. PMID: 20635943 Review. - Catumaxomab, a rat/murine hybrid trifunctional bispecific monoclonal antibody for the treatment of cancer.
Shen J, Zhu Z. Shen J, et al. Curr Opin Mol Ther. 2008 Jun;10(3):273-84. Curr Opin Mol Ther. 2008. PMID: 18535935 - Diabodies: molecular engineering and therapeutic applications.
Wu C. Wu C. Drug News Perspect. 2009 Oct;22(8):453-8. Drug News Perspect. 2009. PMID: 20016854 Review. - Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J, Ghayur T. Gu J, et al. Methods Enzymol. 2012;502:25-41. doi: 10.1016/B978-0-12-416039-2.00002-1. Methods Enzymol. 2012. PMID: 22208980 - Recombinant bispecific antibodies for cellular cancer immunotherapy.
Müller D, Kontermann RE. Müller D, et al. Curr Opin Mol Ther. 2007 Aug;9(4):319-26. Curr Opin Mol Ther. 2007. PMID: 17694444 Review.
Cited by
- Chemical generation of bispecific antibodies.
Doppalapudi VR, Huang J, Liu D, Jin P, Liu B, Li L, Desharnais J, Hagen C, Levin NJ, Shields MJ, Parish M, Murphy RE, Del Rosario J, Oates BD, Lai JY, Matin MJ, Ainekulu Z, Bhat A, Bradshaw CW, Woodnutt G, Lerner RA, Lappe RW. Doppalapudi VR, et al. Proc Natl Acad Sci U S A. 2010 Dec 28;107(52):22611-6. doi: 10.1073/pnas.1016478108. Epub 2010 Dec 13. Proc Natl Acad Sci U S A. 2010. PMID: 21149738 Free PMC article. - Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR.
Michaelson JS, Demarest SJ, Miller B, Amatucci A, Snyder WB, Wu X, Huang F, Phan S, Gao S, Doern A, Farrington GK, Lugovskoy A, Joseph I, Bailly V, Wang X, Garber E, Browning J, Glaser SM. Michaelson JS, et al. MAbs. 2009 Mar-Apr;1(2):128-41. doi: 10.4161/mabs.1.2.7631. Epub 2009 Mar 11. MAbs. 2009. PMID: 20061822 Free PMC article. - Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.
Papo N, Silverman AP, Lahti JL, Cochran JR. Papo N, et al. Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14067-72. doi: 10.1073/pnas.1016635108. Epub 2011 Aug 8. Proc Natl Acad Sci U S A. 2011. PMID: 21825147 Free PMC article. - A bispecific antibody targeting CD47 and CD20 selectively binds and eliminates dual antigen expressing lymphoma cells.
Piccione EC, Juarez S, Liu J, Tseng S, Ryan CE, Narayanan C, Wang L, Weiskopf K, Majeti R. Piccione EC, et al. MAbs. 2015;7(5):946-56. doi: 10.1080/19420862.2015.1062192. MAbs. 2015. PMID: 26083076 Free PMC article. - T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16.
Pörtner LM, Schönberg K, Hejazi M, Brünnert D, Neumann F, Galonska L, Reusch U, Little M, Haas R, Uhrberg M. Pörtner LM, et al. Cancer Immunol Immunother. 2012 Oct;61(10):1869-75. doi: 10.1007/s00262-012-1339-9. Epub 2012 Sep 14. Cancer Immunol Immunother. 2012. PMID: 22976535 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources